News | February 16, 2012

Children's Hospital of Michigan Cardiovascular Surgeon Testifies on Berlin Heart


February 16, 2012 — Few hospitals have as much experience with the Berlin Heart pediatric ventricular assist device (VAD) as DMC Children's Hospital of Michigan. This is why the U.S. Food and Drug Administration (FDA) was eager to hear testimony from Henry L. Walters III, M.D., the hospital’s chief of cardiovascular surgery. He provided testimony about the device at a recent public hearing. After reviewing the clinical trial data and hearing testimony from Walters and others, the device was approved.

The Berlin Heart is the first VAD made specifically for pediatric patients. VADs are common in adults, but, until recently, were not manufactured in pediatric sizes.

Ventricular assist devices are used when a patient needs a heart transplant, but can't wait for a donor heart to become available. The Berlin Heart assists the failing heart until an appropriate donor heart can be found.

"A few times a year, we are faced with a situation where a child simply can't wait for a heart transplant," Walters said. "In these cases, the Berlin Heart works very well and the children generally stabilize and start to thrive and improve while they wait for a donor heart."

Before the device was approved by the Walters and his colleagues used the Berlin Heart under the FDA's "compassionate use" regulations.

Since 2005, Walters and his colleagues have inserted 14 Berlin Hearts. Of the 14 patients, 10 survived to cardiac transplantation and nine are thriving today - a result directly attributable to the efficacy of the Berlin Heart. The nine survivors ranged in age from six months to 13 years.

Before availability of the Berlin Heart, Walters and his colleagues occasionally adapted an adult ventricular assist device for use in a child, but the results were not optimal and some patients were too small for a modified adult device.

"The Berlin Heart stands alone in filling a tremendous void in the field of pediatric cardiac failure. I can honestly say that of our nine survivors, eight were too small to have possibly accommodated any of the available adult ventricular assist devices. For these patients the Berlin Heart was truly the key to their survival," adds Walters.

The pediatric heart transplant program at the DMC Children's Hospital of Michigan is the largest in the state of Michigan and one of the largest in the Midwest.

For more information: www.childrensdmc.org


Related Content

News | Cardiovascular Surgery

April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest ...

Home April 23, 2024
Home
News | Cardiovascular Surgery

March 20, 2024 — PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable ...

Home March 20, 2024
Home
News | Cardiovascular Surgery

February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...

Home February 26, 2024
Home
Feature | Cardiovascular Surgery

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first ...

Home February 23, 2024
Home
News | Cardiovascular Surgery

January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under ...

Home January 29, 2024
Home
News | Cardiovascular Surgery

January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication ...

Home January 11, 2024
Home
News | Cardiovascular Surgery

December 20, 2023 — The Smidt Heart Institute at Cedars-Sinai has opened an Aortic Surveillance Clinic for the ...

Home December 20, 2023
Home
News | Cardiovascular Surgery

December 18, 2023 — The Department of Cardiovascular Surgery at The Mount Sinai Hospital has received the highest ...

Home December 18, 2023
Home
News | Cardiovascular Surgery

November 2, 2023 — The University of Maryland Medical Center (UMMC) released a statement on the passing of a patient ...

Home November 02, 2023
Home
News | Cardiovascular Surgery

October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of ...

Home October 25, 2023
Home
Subscribe Now